NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Telix and certain of its officers and/or […]
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ:CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Confluent and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of BellRing Brands, Inc. ("BellRing" or the "Company") (NYSE:BRBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether BellRing and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE:INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inspire and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fluor Corporation ("Fluor" or the "Company") (NYSE:FLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fluor and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ:LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lantheus and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Six Flags Entertainment Corporation ("Six Flags" or the "Company") (NYSE:FUN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Six Flags and certain of
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ:SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sensus and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Spirit Aviation Holdings, Inc.("Spirit" or the "Company") (NYSE:FLYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spirit and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of James Hardie Industries plc ("James Hardie" or the "Company") (NYSE:JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether James Hardie and certain of